Adverse drug events (ADEs)--injuries caused by medications-- are estimated to rank among the leading causes of death in the United States and represent a major, often preventable threat to patient ...

Adverse drug events are more common in older people with comorbidities, a new study finds. Factors that are independently linked with adverse drug events are being female, taking more drugs daily, ...

The evaluation of drug safety in clinical trials is a critical element of the drug development process, ensuring that therapeutic benefits outweigh potential harms. Clinical trials, particularly in ...

Among adults treated for community-acquired pneumonia in the outpatient setting, broad-spectrum antibiotics vs macrolide monotherapy were associated with an increased risk for adverse drug events.

Adverse drug events can add approximately $3,000 to hospitalization costs, according to research published in the Joint Commission Journal on Quality and Patient Safety. For their study, researchers ...

The FDA launched AEMS, a unified platform that replaces fragmented legacy databases to enable real-time adverse event reporting.

The assessment of causation for a potential drug interaction requires thoughtful consideration of the properties of both the object and precipitant drugs, patient-specific factors, and the possible ...

The FDA has launched a new adverse event reporting system that will consolidate several systems it has for reporting different types of adverse events, the agency announced Wednesday. The new system, ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...

Marketing Surveillance (PMS), often referred to as Phase IV clinical trials, is the systematic and ongoing monitoring of a drug's safety, efficacy, and real-world performance after it receives ...